Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NanoSphere Health Sciences Inc C.NSHS

Alternate Symbol(s):  NSHSF

Healthcare Cannabis
NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. It has created a patented NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical... see more

Recent & Breaking News (CSE:NSHS)

CSE Bulletin: Consolidation - NanoSphere Health Sciences Inc. (NSHS)

Newsfile July 5, 2021

NanoSphere Provides Update on United States Operations

GlobeNewswire December 9, 2019

NanoSphere Health Sciences Inc. News Release

GlobeNewswire November 29, 2019

NanoSphere Provides Update on Canadian Operations

GlobeNewswire November 4, 2019

NanoSphere Health Sciences Inc. News Release

GlobeNewswire July 16, 2019

NanoSphere Health Sciences Announces Retirement of CEO Robert E. Sutton; Dr. Mark Percival Named As Successor

GlobeNewswire June 10, 2019

Colorado Passes Law Allowing Doctors to Prescribe Cannabis in Place of Opioids

GlobeNewswire May 29, 2019

Cannabis Cosmeceuticals: A NEW Market With A $700B Prize

Jeff Nielson May 8, 2019

NanoSphere Health Sciences and Stat Shield Technology Form Strategic Partnership to Launch Evolve Products for Veterans

GlobeNewswire May 2, 2019

NanoSphere and Vertical Unveil the Future of Cannabis at Hall of Flowers Trade Show

GlobeNewswire April 30, 2019

Cannabis ‘Breakthrough’ Patent BROADENED For General Pharma Use

Stockhouse Editorial April 24, 2019

IIROC Trade Resumption - NSHS

Canada NewsWire April 24, 2019

NanoSphere Health Sciences Has Received Notice of Allowance for a Patent for its Breakthrough Nanoparticle Encapsulations of NSAIDs

GlobeNewswire April 24, 2019

Record Revenues for Manitoba Cannabis Powerhouse

Jeff Nielson April 23, 2019

IIROC Trading Halt - NSHS

Canada NewsWire April 22, 2019

NanoSphere Products Approved for Sale in California Cannabis Market

GlobeNewswire April 2, 2019

NanoSphere Engages Chaé Manufacturing to Increase Production

GlobeNewswire March 14, 2019

NanoSphere Developing Production Lab at Delta 9 Cannabis

Business Wire March 7, 2019

NanoSphere Closes $2 Million Private Placement Offering

Business Wire February 21, 2019

NanoSphere Signs Definitive Licensing Agreement in Oregon

Business Wire February 20, 2019